Page 124 - 《中国药房》2025年20期

长期纵向研究，进一步基于肠道菌群探索新的干预策 Psychiatry，2019，53（12）：1151-1166.
略，以增强SSRIs的抗抑郁作用，为抑郁症综合治疗开拓 [13] DIVICCARO S，GIATTI S，CIOFFI L，et al. Paroxetine
更多有效途径。 effects in adult male rat colon：focus on gut steroidoge-
参考文献 nesis and microbiota[J]. Psychoneuroendocrinology，2022，
[ 1 ] BLIER P. Neurobiology of depression and mechanism of 143：105828.
action of depression treatments[J]. J Clin Psychiatry， [14] MA T R，XUE X L，TIAN H，et al. Effect of the gut micro‐
2016，77（3）：e319. biota and their metabolites on postoperative intestinal mo‐
[ 2 ] RUSH A J，TRIVEDI M H，WISNIEWSKI S R，et al. tility and its underlying mechanisms[J]. J Transl Med，
Acute and longer-term outcomes in depressed outpatients 2023，21（1）：349.
requiring one or several treatment steps：a STAR*D report [15] ZHANG W J，QU W，WANG H，et al. Antidepressants
[J]. Am J Psychiatry，2006，163（11）：1905-1917. fluoxetine and amitriptyline induce alterations in intestinal
[ 3 ] WANG H X，WANG Y P. Gut microbiota-brain axis[J]. microbiota and gut microbiome function in rats exposed to
Chin Med J（Engl），2016，129（19）：2373-2380. chronic unpredictable mild stress[J]. Transl Psychiatry，
[ 4 ] SIMPSON C A，DIAZ-ARTECHE C，ELIBY D，et al. The 2021，11（1）：131.
gut microbiota in anxiety and depression：a systematic re‐ [16] WANG Y P，ZHOU J J，YE J B，et al. Multi-omics reveal
view[J]. Clin Psychol Rev，2021，83：101943. microbial determinants impacting the treatment outcome
[ 5 ] YANG C L，HU T J，XUE X，et al. Multi-omics analysis of antidepressants in major depressive disorder[J]. Micro‐
of fecal microbiota transplantation’s impact on functional biome，2023，11（1）：195.
constipation and comorbid depression and anxiety[J]. [17] SHEN Y，YANG X，LI G F，et al. The change of gut micro-
BMC Microbiol，2023，23（1）：389. biota in MDD patients under SSRIs treatment[J]. Sci Rep，
[ 6 ] SUN L J，ZHANG H H，CAO Y，et al. Fluoxetine amelio‐ 2021，11（1）：14918.
rates dysbiosis in a depression model induced by chronic [18] DUAN J J，HUANG Y，TAN X M，et al. Characterization
unpredicted mild stress in mice[J]. Int J Med Sci，2019，16 of gut microbiome in mice model of depression with diver‐
（9）：1260-1270. gent response to escitalopram treatment[J]. Transl Psychia‐
[ 7 ] JIANG Y，QU Y C，SHI L Y，et al. The role of gut micro‐ try，2021，11（1）：303.
biota and metabolomic pathways in modulating the effi‐ [19] FONTANA A，MANCHIA M，PANEBIANCO C，et al.
cacy of SSRIs for major depressive disorder[J]. Transl Exploring the role of gut microbiota in major depressive
Psychiatry，2024，14（1）：493. disorder and in treatment resistance to antidepressants[J].
[ 8 ] XIE Y J，ZHU H W，YUAN Y L，et al. Baseline gut micro‐ Biomedicines，2020，8（9）：311.
biota profiles affect treatment response in patients with [20] LIU X J，LI M Y，JIAN C，et al. Characterization of
depression[J]. Front Microbiol，2024，15：1429116. “microbiome-metabolome-immunity” in depressed rats
[ 9 ] LIN S K，CHEN H C，CHEN C H，et al. Exploring the hu‐ with divergent responses to paroxetine[J]. J Affect Disord，
man gut microbiota targets in relation to the use of con‐ 2024，352：201-213.
temporary antidepressants[J]. J Affect Disord，2024，344： [21] GENG J F，NI Q Q，SUN W，et al. The links between gut
473-484. microbiota and obesity and obesity related diseases[J].
[10] GAO M X，TU H W，LIU P H，et al. Association analysis Biomed Pharmacother，2022，147：112678.
of gut microbiota and efficacy of SSRIs antidepressants in [22] PORTINCASA P，BONFRATE L，VACCA M，et al. Gut
patients with major depressive disorder[J]. J Affect Disord， microbiota and short chain fatty acids：implications in glu‐
2023，330：40-47. cose homeostasis[J]. Int J Mol Sci，2022，23（3）：1105.
[11] MUNOZ-BELLIDO J L，MUNOZ-CRIADO S，GARCÌA- [23] RYAN E，JOYCE S A，CLARKE D J. Membrane lipids
RODRÌGUEZ J A. Antimicrobial activity of psychotropic from gut microbiome-associated bacteria as structural and
drugs：selective serotonin reuptake inhibitors[J]. Int J Anti‐ signalling molecules[J]. Microbiology（Reading），2023，
microb Agents，2000，14（3）：177-180. 169（3）：001315.
[12] MCGOVERN A S，HAMLIN A S，WINTER G. A review [24] DUAN J J，SUN J X，MA X，et al. Association of
of the antimicrobial side of antidepressants and its puta‐ escitalopram-induced shifts in gut microbiota and sphingo‐
tive implications on the gut microbiome[J]. Aust N Z J lipid metabolism with depression-like behavior in Wistar-

· 2602 · China Pharmacy 2025 Vol. 36 No. 20 中国药房 2025年第36卷第20期